Auteurs
Analysis
Allemagne
Racine
Analysis
Allemagne
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Allemagne)

Index « Auteurs » - entrée « Danilo Fliser »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Danilo Dragoni117 < Danilo Fliser < Danilo Piobbico  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000756 (2016) Francesco Locatelli [Italie] ; Gabriel Choukroun [France] ; Matt Truman [Australie] ; Alfons Wiggenhauser [Allemagne] ; Danilo Fliser [Allemagne]Once-Monthly Continuous Erythropoietin Receptor Activator (C.E.R.A.) in Patients with Hemodialysis-Dependent Chronic Kidney Disease: Pooled Data from Phase III Trials
000F85 (2014) Iain C. Macdougall [Royaume-Uni] ; Nicole Casadevall [France] ; Francesco Locatelli [Italie] ; Christian Combe [France] ; Gerard M. London [France] ; Salvatore Di Paolo [Italie] ; Andreas Kribben [Allemagne] ; Danilo Fliser [Allemagne] ; Hans Messner [Canada] ; John Mcneil [Australie] ; Paul Stevens [Royaume-Uni] ; Antonio Santoro [Italie] ; Angel L. M. De Francisco [Espagne] ; Paul Percheson [États-Unis] ; Anna Potamianou [États-Unis] ; Arnaud Foucher [États-Unis] ; Daniel Fife [États-Unis] ; Véronique Mérit [États-Unis] ; Els Vercammen [États-Unis]Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS)
002320 (2007) Harald Mischak [Allemagne] ; Rolf Apweiler [Royaume-Uni] ; Rosamonde E. Banks [Royaume-Uni] ; Mark Conaway [États-Unis] ; Joshua Coon [États-Unis] ; Anna Dominiczak [Royaume-Uni] ; Jochen H. H. Ehrich [Allemagne] ; Danilo Fliser [Allemagne] ; Mark Girolami [Royaume-Uni] ; Henning Hermjakob [Royaume-Uni] ; Denis Hochstrasser [Allemagne, Suisse] ; Joachim Jankowski [Allemagne] ; Bruce A. Julian [États-Unis] ; Walter Kolch [Royaume-Uni] ; Ziad A. Massy [France] ; Christian Neusuess [Allemagne] ; Jan Novak [États-Unis] ; Karlheinz Peter [Australie] ; Kasper Rossing [Danemark] ; Joost Schanstra [France] ; O. John Semmes [États-Unis] ; Dan Theodorescu [États-Unis] ; Visith Thongboonkerd [Thaïlande] ; Eva M. Weissinger [Allemagne] ; Jennifer E. Van Eyk [États-Unis] ; Tadashi Yamamoto [Japon]Clinical proteomics: A need to define the field and to begin to set adequate standards

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Aged
2Anemia (drug therapy)
2Female
2Humans
2Male
2Middle Aged
1Abundant proteins
1Adult
1Aged, 80 and over
1Analytical approach
1Analytical performance
1Analytical platforms
1Anemia (diagnosis)
1Anemia (etiology)
1Appl
1Application platform
1Appropriate quality control
1Assay
1Autoantibodies (blood)
1Biomarker
1Biomarker discovery
1Biomarkers
1Body fluids
1Cancer inst
1Cancer research
1Clear definition
1Clin
1Clinical
1Clinical Trials, Phase III as Topic
1Clinical centre
1Clinical conditions
1Clinical data
1Clinical diagnosis
1Clinical platform
1Clinical practice
1Clinical problem
1Clinical proteomic studies
1Clinical proteomic study
1Clinical proteomics
1Clinical proteomics studies
1Clinical proteomics study
1Clinical study
1Clinical trials
1Clinician
1Darbepoetin alfa (immunology)
1Data analysis
1Data processing
1Datasets
1Development pipeline
1Diagnostics
1Different groups
1Different samples
1Discovery platform
1Dose-Response Relationship, Drug
1Dynamic ranges
1Entire process
1Epidemiological studies
1Epoetin Alfa (immunology)
1Erythropoietin (immunology)
1Erythropoietin (pharmacology)
1Gmbh
1Guideline
1Hannover
1Hematinics (pharmacology)
1Hemoglobins (analysis)
1Incidence
1Kgaa
1Laboratory practice
1Large number
1Many studies
1Mischak
1Molecular signature
1Outcome and Process Assessment (Health Care)
1Past experience
1Pilot study
1Polyethylene Glycols (pharmacology)
1Potential biomarkers
1Precise definition
1Prognosis
1Prospective Studies
1Proteome
1Proteome analysis
1Proteome data
1Proteomic
1Proteomic analyses
1Proteomics
1Proteomics clin
1Protocol
1Quality control
1Quality control criteria
1Randomized Controlled Trials as Topic
1Recombinant Proteins (immunology)
1Red-Cell Aplasia, Pure (epidemiology)
1Red-Cell Aplasia, Pure (immunology)
1Registries
1Relative quantification
1Renal Dialysis (adverse effects)
1Renal Dialysis (methods)
1Renal Insufficiency, Chronic (complications)
1Renal Insufficiency, Chronic (therapy)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Danilo Fliser" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i  \
                -Sk "Danilo Fliser" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Allemagne
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Danilo Fliser
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024